home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
News Page

The news
and
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
Archives
News archive 1997-2008
 

Canada and European Communities end WTO agricultural biotech dispute - EU approval system for ag biotech products continues to be “broken”


Washington, DC
July 16, 2009

Canada and the European Communities announced the end of a six-year World Trade Organization (WTO) dispute regarding the approval and marketing of biotechnology products.

Sharon Bomer Lauritsen, Executive Vice President, Food and Agriculture for the
Biotechnology Industry Organization (BIO), issued the following statement in response:

“While it is a good sign to see that Canadian canola growers have gained some access for their exports, the European Union’s approval system for agricultural biotechnology products continues to be broken. It is plagued by political interference, undue delay and member state prohibitions.

“There are now 70 products awaiting approvals – compared to 40 last year. There are no new cultivation approvals – in fact – France and Germany have imposed cultivation bans within the past two years. In addition, biotech corn is still not moving into the EU.

“This situation impedes U.S. trade, despite the well-documented safety of agricultural biotechnology which has produced real results towards increasing crop yields, reducing production inputs and enhancing environmental sustainability.

“The EU’s non-functioning biotech approval process has blocked U.S. agricultural exports to the detriment of American farmers and agribusiness, but also has prevented European farmers from benefiting from modern technologies that are used in 25 countries by 13.3 million farmers around the world.

“Trade problems will continue to exist until Europe has a science-based, timely and predictable approval process, which could be achieved if the EU simply followed its own laws and regulations.

“We urge the European Commission to normalize trade of products produced through biotechnology in a timely and science-based manner.”

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.



More news from: Biotechnology Innovation Organization (BIO)


Website: http://www.bio.org

Published: July 16, 2009

The news item on this page is copyright by the organization where it originated
Fair use notice

 
 
 
 
 
 
 
 
 
 
 

  Archive of the news section

 


Copyright @ 1992-2026 SeedQuest - All rights reserved